Recerca

Àrea 1

Malalties autoimmunes sistèmiques

Articles de l'any 2010
Original

Originals publicats: 31

Factor d'impacte: mitjana: 5.29, total: 164.1

  • Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

    Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA
    ANN RHEUM DIS. 2010; 69: 20-28. IF: 8.111

  • The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

    Houssiau FA, Vasconcelos C, D'cruz D, Sebastiani GD, Garrido ED, Danieli MG, Abramovicz D, Blockmans D, Cauli A, Direskeneli H, Galeazzi M, Gul A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R
    ANN RHEUM DIS. 2010; 69: 61-64. IF: 8.111

  • Increased expression of the endothelin system in arterial lesions from patients with giant-cell arteritis: association between elevated plasma endothelin levels and the development of ischaemic events

    Lozano E, Segarra M, Corbera-Bellalta M, Garcia-Martinez A, Espigol-Frigole G, Pla-Campo A, Hernandez-Rodriguez J, Cid MC
    ANN RHEUM DIS. 2010; 69: 434-442. IF: 8.111

  • Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

    Houssiau FA, D'cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C, Garrido ED, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, LeGuern V, Depresseux G, Guillevin L, Cervera R
    ANN RHEUM DIS. 2010; 69: 2083-2089. IF: 8.111

  • Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus

    Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Wallace DJ, Clarke A, Bernatsky S, Isenberg D, Rahman A, Alarcon GS, Gladman DD, Fortin PR, Sanchez-Guerrero J, Romero-Diaz J, Merrill JT, Ginzler E, Bruce IN, Steinsson K, Khamashta M, Petri M, Manzi S, Dooley MA, Ramsey-Goldman R, VanVollenhoven R, Nived O, Sturfelt G, Aranow C, Kalunian K, Ramos-Casals M, Zoma A, Douglas J, Thompson K, Farewell V
    ANN RHEUM DIS. 2010; 69: 529-535. IF: 8.111

Revisió

Revisions publicades: 7

Factor d'impacte: mitjana: 3.62, total: 25.34

  • Autoimmune diseases induced by biological agents A double-edged sword?

    Ramos-Casals M, ROBERTO-PEREZ-ALVAREZ, Diaz-Lagares C, Cuadrado MJ, Khamashta MA
    AUTOIMMUN REV. 2010; 9: 188-193. IF: 6.368

  • Catastrophic antiphospholipid syndrome: Updated diagnostic algorithms

    Erkan D, Espinosa G, Cervera R
    AUTOIMMUN REV. 2010; 10: 74-79. IF: 6.368

Editorials

Editorials publicades: 1

Factor d'impacte: mitjana: 3.71, total: 3.71

  • Antiphospholipid syndrome: long-time research on pathogenic mechanisms has finally lead to new therapeutic strategies

    Cervera R, Espinosa G
    EXPERT OPIN THER TAR. 2010; 14: 1279-1282. IF: 3.713

Multicèntrics

Multicèntrics publicats: 1

Factor d'impacte: mitjana: 7.33, total: 7.33

  • Nonrenal Disease Activity Following Mycophenolate Mofetil or Intravenous Cyclophosphamide as Induction Treatment for Lupus Nephritis

    Ginzler EM, Wofsy D, Isenberg D, Gordon C, Lisk L, Dooley MA
    ARTHRITIS RHEUM-US. 2010; 62: 211-221. IF: 7.332

Guies clíniques

Guies clínique publicades: 3

Factor d'impacte: mitjana: 8.11, total: 24.33

  • EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

    Bertsias GK, Ioannidis JPA, Aringer M, Bollen E, Bombardieri S, Bruce IN, Cervera R, Dalakas M, Doria A, Hanly JG, Huizinga TWJ, Isenberg D, Kallenberg C, Piette JC, Schneider M, Scolding N, Smolen J, Stara A, Tassiulas I, Tektonidou M, Tincani A, VanBuchem MA, VanVollenhoven R, Ward M, Gordon C, Boumpas DT
    ANN RHEUM DIS. 2010; 69: 2074-2082. IF: 8.111

  • EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

    Basu N, Watts R, Bajema I, Baslund B, Bley T, Boers M, Brogan P, Calabrese L, Cid MC, Cohen-Tervaert JW, Flores-Suarez LF, Fujimoto S, DeGroot K, Guillevin L, Hatemi G, Hauser T, Jayne D, Jennette C, Kallenberg CGM, Kobayashi S, Little MA, Mahr A, Mclaren J, Merkel PA, Ozen S, Puechal X, Rasmussen N, Salama A, Salvarani C, Savage C, Scott DGI, Segelmark M, Specks U, Sunderkoetter C, Suzuki K, Tesar V, Wiik A, Yazici H, Luqmani R
    ANN RHEUM DIS. 2010; 69: 1744-1750. IF: 8.111

Més articles
Tesis
  • Consecuencias clínicas de la persistencia de actividad inflamatoria en la arteritis de células gigantes. Estudio de factores implicados.

    Doctorand: Ana García Martínez,
    Director/s: Cid MC

  • Impacto de la enfermedad cardiovascular en el síndrome de Sjögren primario

    Doctorand: Marta Perez de Lis Novo,
    Director/s: Coca A, Ramos M